LIGAND PHARMACEUTICALS INCORPORATED Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $1.58 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2018-05-09
- 2018-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $1.58M.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $1.70M.
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $2.52M.
- 2017-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $2.06M.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2018-03-31 | $1.58M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.70M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $2.52M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.06M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $2.14M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.56M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $3.02M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $3.33M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $2.99M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $4.94M 10-Q · filed 2016-11-14 |
| 2015-09-30 | $5.57M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $11.28M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $4.95M 10-K · filed 2016-11-14 |